Also trades as: ATIP-WT (NYSE) · $vol 0M
ATIP OTC
ATI Physical Therapy, Inc.
1W: +87.5%
1M: -32.5%
3M: -20.9%
1Y: -89.3%
3Y: -98.9%
$0.68
Last traded 2025-08-01 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$753M
+7.7% ▲
5Y CAGR: -0.8%
Gross Profit
$103M
+6.9% ▲
5Y CAGR: -12.4%
Operating Income
$2M
+108.3% ▲
5Y CAGR: -47.9%
Net Income
-$58M
+16.5% ▲
EPS (Diluted)
$-19.46
+39.1% ▲
EBITDA
$2M
-93.5% ▼
5Y CAGR: -52.8%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $592M | $628M | $636M | $699M | $753M |
| YoY Growth | -24.6% | +6.0% | +1.2% | +10.0% | +7.7% |
| Cost of Revenue | $473M | $517M | $561M | $602M | $650M |
| Gross Profit | $120M | $110M | $75M | $97M | $103M |
| Gross Margin | 20.2% | 17.6% | 11.8% | 13.8% | 13.7% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $104M | $112M | $115M | $119M | $100M |
| Operating Expenses | $121M | $128M | $129M | $124M | $101M |
| Operating Income | $90M | -$32M | -$57M | -$28M | $2M |
| Operating Margin | 15.2% | -5.1% | -8.9% | -3.9% | 0.3% |
| Interest Expense | $88M | $56M | $45M | $61M | $58M |
| Income Before Tax | $2M | -$853M | -$542M | -$64M | -$57M |
| Tax Expense | $2M | -$71M | -$49M | $3M | $1M |
| Net Income | -$298K | -$782M | -$493M | -$70M | -$58M |
| Net Margin | -0.1% | -124.6% | -77.6% | -10.0% | -7.7% |
| EPS (Diluted) | $-0.12 | $-235.83 | $-121.35 | $-31.93 | $-19.46 |
| EBITDA | $174M | -$713M | -$407M | $35M | $2M |
| Shares Outstanding | 3M | 3M | 4M | 4M | 4M |